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Data collection and processing 
Magnification 81,000 81,000 81,000 
Voltage (kV) 300 300 300 
Electron exposure (e-/ Å2) 80 80 80 
Defocus range (μm) -0.5 ~ -3.0 -0.5 ~ -3.0 -0.5 ~ -3.0 
Pixel size (Å) 1.045 1.045 1.045 
Symmetry imposed C1 C1 C1 
Initial particle projections (no.) 3, 405, 355 4, 680, 972 4, 270, 010 
Final particle projections (no.) 555, 628 499, 924 140, 602 
Map resolution (Å) 2.9 3.1 3.2 
FSC threshold 0.143 0.143 0.143 
Map resolution range (Å) 2.3- 4.3 2.3- 4.3 2.3- 4.3 
Refinement 
Initial model used 
(PDB accession number) 
6OIJ 6NBF 6OMM 
Model resolution (Å) 3.0 3.2 3.4 
FSC threshold 0.5 0.5 0.5 
Map sharpening B-factor (Å2) -97.47 -134.32 -111.38 
Model composition 
Non-hydrogen atoms 8999 7196 8860 
Protein residues 1170 922 1153 
B-factors (Å2) 
Protein 56.03 66.86 63.12 
RMSD 
Bond lengths (Å) 0.010 0.010 0.002 
Bond angles (°) 1.027 1.010 0.625 
Validation 
MolProbity score 1.45 1.39 1.35 
Clashscore 4.50 3.85 2.45 
Rotamer outliers (%) 0.21 0.26 0.00 
Ramachandran Plot 
Favored (%) 96.51 96.57 95.40 
Allowed (%) 3.49 3.43 4.60 
Disallowed (%) 0.00 0.00 0.00 
Supplementary Table 2. Effects of mutations in the ligand-binding pocket of CCKAR on CCK-
8 binding affinities. 
Radiolabeled ligand ([125I]CCK-8) binding assay was performed to evaluate the ligand-binding 
affinity of CCKAR mutants. Binding data are represented mean pKi ± S.E.M. **P<0.01, versus wild-
type (WT). N.D., not determined. FACS analyses were performed to evaluate the surface expression 
of the CCKAR mutants. Expression data are shown as %WT. †P < 0.05, ††P < 0.01, †††P < 0.001, 
††††P < 0.0001, versus WT. All data were analyzed by one-way ANOVA Dunnett multiple 
comparisons test. No adjustments were made for multiple comparisons. 
 
Mutant pKi ± S.E.M. n P value Expression % n P value 
WT 8.58 ± 0.12 4 1 100 3 1 
K105A 7.78 ± 0.22** 3 0.0089 77.86 ± 6.24†† 3 0.0020 
F107A N.D. 3 — 71.85 ± 6.84 3 0.0994 
T118A 8.73 ± 0.13 3 0.9921 78.06 ± 5.38† 3 0.0153 
M121A 8.03 ± 0.15 3 0.1191 74.99 ± 5.48† 3 0.0426 
V125A 8.68 ± 0.12 3 0.9993 46.48 ± 1.03†††† 3 <0.0001 
Y176A N.D. 3 — 26.63 ± 2.43†††† 3 <0.0001 
F185A 7.98 ± 0.24 3 0.0742 77.98 ± 4.85 3 0.1029 
M195A 8.10 ± 0.26 3 0.2199 85.45 ± 4.52 3 0.5581 
C196A N.D. 3 — 3.24 ± 0.06†††† 3 <0.0001 
R197A N.D. 3 — 104.14 ± 5.14 3 0.9993 
H210A 8.61 ± 0.12 3 0.9998 81.19 ± 4.32 3 0.2350 
I329A N.D. 3 — 74.22 ± 7.37† 3 0.0334 
F330A 8.67 ± 0.09 3 0.9994 27.31 ± 2.74†††† 3 <0.0001 
A332G 8.43 ± 0.12 3 0.9921 32.50 ± 4.21†††† 3 <0.0001 
N333A N.D. 3 — 63.96 ± 3.31††† 3 0.0009 
R336A N.D. 3 — 82.96 ± 5.35 3 0.3489 
A343G N.D. 3 — 50.61 ± 5.37†††† 3 <0.0001 
E344A N.D. 3 — 88.00 ± 13.77 3 0.7932 
L347A N.D. 3 — 52.59 ± 1.43†††† 3 <0.0001 
S348A N.D. 3 — 98.35 ± 8.18 3 0.9997 
I352A N.D. 3 — 80.35 ± 1.26 3 0.1918 
Y360A 8.00 ± 0.09 3 0.0899 82.85 ± 6.85 3 0.3411 
  
Supplementary Table 3. Coupling activity of CCKAR with different G proteins. 
BRET assay was performed to evaluate the coupling activity of CCKAR with different G proteins. 
Coupling activity data are represented as mean pEC50 ± S.E.M. Decreased fold of Emax compared to 
Gq was calculated. BRET experiments were performed in sextuplicate (n=6). Coupling activity data 
were analyzed by one-way ANOVA Dunnett multiple comparisons test. P values, versus Receptor 
+ Gq. Radiolabeled ligand binding assay was used to evaluate the allosteric effects of different G 
proteins on the binding affinity of CCK-8. The binding affinities are indicated as pKi ± S.E.M. 
Binding experiments were performed in triplicate (n=3). Binding data were analyzed by one-way 
ANOVA Dunnett multiple comparisons test. *P<0.05, versus receptor.  
 
Group 
G protein-coupling activity of CCKAR Binding affinity of CCK-8 
pEC50 ± S.E.M. n P value 
Decreased fold  
of Emax 
pKi ± S.E.M. n P value 
Receptor — — — — 7.92 ± 0.06 3 1 
Receptor + Gq 8.42 ± 0.08 6 1 1 8.28 ± 0.08* 3 0.0143 
Receptor + Gi 7.32 ± 0.22 6 0.1230 6.60 7.87 ± 0.07 3 0.9148 
Receptor + Gs 7.92 ± 0.65 6 0.5898 20.33 8.02 ± 0.06 3 0.6189 
  
Supplementary Table 4. Effect of I296G mutation of CCKAR on G protein-coupling activity. 
BRET-based NanoBiT G-protein recruitment and NanoBiT G-protein dissociation assays were 
performed to evaluate Gq-, Gi-, and Gs-coupling activity, respectively. Data are represented as mean 
pEC50 ± S.E.M. FACS analyses were performed to evaluate the surface expression of CCKAR 
mutant. Radiolabeled ligand binding assay was used to evaluate the effects of the mutation on the 
binding affinity of CCK-8. The binding affinities are indicated as pKi ± S.E.M. All data were 
analyzed by two-tailed Student’s t-test by comparing I296G mutants with wild-type (WT) receptor. 
**P<0.01, versus WT. All experiments were performed in triplicate (n=3). 
 
Mutant 





pEC50 ± S.E.M. 
Expression % pKi ± S.E.M. 
Gq Gi Gs 
WT 9.14 ± 0.04 6.81 ± 0.12 10.48 ± 0.10 100 8.58 ± 0.12 
I296G 8.38 ± 0.09** 6.66 ± 0.08 10.46 ± 0.20 99.52 ± 3.10 8.63 ± 0.13 
n 3 3 3 3 3 






Supplementary Fig. 1│Cryo-EM workflows for structure determination of CCKAR–Gq 
protein complex. a, Size exclusion chromatography (SEC) profile and SDS-PAGE analysis of the 
CCK-8–CCKAR–Gq–scFv16 protein complex sample. b, Representative cryo-EM micrograph 
(scale bar, 30 nm) and 2D classification averages (scale bar, 5 nm) of the CCK-8–CCKAR–Gq–
scFv16 complex. The data collection was performed once. The 2D averages display different 
secondary features in different views. c, Single-particle cryo-EM data processing flowcharts of the 
CCK-8–CCKAR–Gq–scFv16 by Relion 3.1, including the Euler angle distribution of particles used 
in the final refinement and the fourier shell correlation (FSC) curves. The global resolution defined 






Supplementary Fig. 2│ Cryo-EM workflows for structure determination of CCKAR–Gs 
protein complex. 
a, Size exclusion chromatography (SEC) profile and SDS-PAGE analysis of the CCK-8–CCKAR–
Gs protein complex sample. b, Representative cryo-EM micrograph (scale bar, 30 nm) and 2D 
classification averages (scale bar, 5 nm) of the CCK-8–CCKAR–Gs complex. The data collection 
was performed once. The 2D averages display different secondary features in different views. c, 
Single-particle cryo-EM data processing flowcharts of the CCK-8–CCKAR–Gs by Relion 3.0, 
including the Euler angle distribution of particles used in the final refinement and the fourier shell 
correlation (FSC) curves. The global resolution defined at the FSC=0.143 is 3.1 Å.  
  
 
Supplementary Fig. 3│ Cryo-EM workflows for structure determination of CCKAR–Gi 
protein complex. 
a, Size exclusion chromatography (SEC) profile and SDS-PAGE analysis of the CCK-8–CCKAR–
Gi–scFv16 protein complex sample. b, Representative cryo-EM micrograph (scale bar, 30 nm) and 
2D classification averages (scale bar, 5 nm) of the CCK-8–CCKAR–Gi–scFv16 complex. The data 
collection was performed once. The 2D averages display different secondary features in different 
views. c, Single-particle cryo-EM data processing flowcharts of the CCK-8–CCKAR–Gi–scFv16 by 
Relion 3.0, including the Euler angle distribution of particles used in the final refinement and the 






Supplementary Fig. 4│ Receptor and Gα subunits used in the cryo-EM structure 
determination. a, A schematic illustration of the CCKAR construct used in cryo-EM studies. HA, 
hemagglutinin signal sequence; 2MBP, double-MBP tag. b, Protein sequences of Gαq, Gαs, and 
Gαi1 subunits. N-terminal sequence replaced in Gαs and Gαq is shown in blue. The two dominant-
negative mutations are colored red and underlined. Stabilization mutations derived from the reported 
mini-Gαs are highlighted in cyan. AHD domain of the Gαs is replaced with the equivalent region of 
Gαi1 and colored in gray. 
  
 
Supplementary Fig. 5│ Local cryo-EM density maps of CCKAR–G protein complexes. a, 
Cryo-EM density maps of TM1-TM7, ECL1-ECL3, ICL2, ICL3, CCK-8 peptide and α5 helix of 
Gαq in the CCK-8–CCKAR–Gq–scFv16 structure. b, Cryo-EM density maps of TM1-TM7, ECL1-
ECL3, ICL2, CCK-8 peptide and α5 helix of Gαs in the CCK-8–CCKAR–Gs structure. c, Cryo-EM 
density maps of TM1-TM7, ECL1-ECL3, ICL2, CCK-8 peptide and α5 helix of Gαi in the CCK-8–
CCKAR–Gi–scFv16 structure. d-f, The global density maps of the CCK-8–CCKAR–Gq–scFv16 (d), 
CCK-8–CCKAR–Gs (e), and CCK-8–CCKAR–Gi–scFv16 (f) colored by local resolution (Å). The 
density maps are shown at thresholds of 0.08, 0.055 and 0.05 for the CCKAR–Gq, CCKAR–Gs and 
CCKAR–Gi complex, respectively. 
  
 
Supplementary Fig. 6│ Gating strategy of cell surface expression assay. Circle a gate E1 in the 
scatter map (red circle). The cells shown in the density map are all the cells in the gate E1 in the 
scatter map. Fluorescence signal intensity (FITC) is presented by density map. With the Blank 
sample as the reference value of background fluorescence signal (a), the “quadrant gate” divides the 
fluorescence signal density map into four quadrants. The third quadrant represents the negative cell 
community, while the fourth quadrant represents the positive cell community. The expression level 
of cell surface wild-type (WT) CCKAR (b) can be calculated as follows: (M(Q2-4)-M(Q2-3))(Q2-
4% Parent). M, mean fluorescence intensity. The expression level of the CCKAR mutant is 
calculated similarly to WT CCKAR and then is normalized with the WT to calculate the relative 
expression value. 
